Pn-018-0302.7z -

However, the identifier "0302" frequently appears in the context of on ClinicalTrials.gov , particularly focusing on:

If it is related to a , I can look up the specific protocol ID if you have it. PN-018-0302.7z

A Phase II study of LM-302 combined with toripalimab for CLDN18.2 positive gastro-intestinal cancer, which was discussed at ASCO 2025. However, the identifier "0302" frequently appears in the

Based on the search results, there is no direct reference to a published paper specifically named or indexed under the filename "." PN-018-0302.7z